1.Molecular Analysis of Protease and Reverse Transcriptase in an AIDS Patient with HAART - Failure.
Young Keol CHO ; Hee Jung LEE ; Heui Ran LEE ; Yoo Kyum KIM
Journal of Bacteriology and Virology 2001;31(1):63-68
No abstract available.
Antiretroviral Therapy, Highly Active*
;
Humans
;
RNA-Directed DNA Polymerase*
2.Original Articles: Immunogenicity and Safety of a 20 microgram Dose of the Green Cross Recombinant Hepatitis B Vaccine ( HG -II ) in Healthy Adults.
Kye Heui LEE ; Ok Jae LEE ; Young Chai KIM ; Ran NAMGUNG ; Young Mo SOHN
The Korean Journal of Hepatology 1997;3(1):58-64
BACKGROUND/AIMS: The introduction of Hansenula polymorpha for recombinant hepatitis B vaccine production allowed high product yield with plasmid stability and less glycosylation than conventional Saccharomyces cerevisiae system. A Green Cross HG-II vaccine formulated from HBsAg produced by a recombinant strain of the yeast H. polymorpha was evaluated for immunogenicity and safety in an open label triaL METHOFD: A 20 ug dose of Green Cross HG-II vaccine was administered intramuscularly at 0, 1 and 6 months at the deltoid region in 118 healthy adults seronegative for HBV markers. The anti-HBs titers were determined at one month after administration of the third dose of vaccine by radioimmunoassay. RESULTS: The seroconversion rate was 96.8% (90 out of 93), with seroprotective rate of 95.7% (89 out of 93). The geometric mean titers(GMT) of the anti-HBs response was 153.1mIU/ml in seroconverters. An age-dependent effect was observed in the anti-HBs response. But sex-dependent effect was not prominent. Reactogenecity was in incidence and general reactions were short-lasting and a mainly mild in severity. CONCLUSIONS: The results of this study have shown that the Green Cross HG-II vaccine is safe and clinically well tolerated, a nd that it may provide protection against HBV infection.
Adult*
;
Glycosylation
;
Hepatitis B Surface Antigens
;
Hepatitis B Vaccines*
;
Hepatitis B*
;
Hepatitis*
;
Humans
;
Incidence
;
Pichia
;
Plasmids
;
Radioimmunoassay
;
Saccharomyces cerevisiae
;
Yeasts
3.A case of cerebrocostomandibular syndrome with congenital heart disease.
Sang Heui SONG ; Kook In PARK ; Hye Jung JOO ; Ran NAMGUNG ; Chul LEE ; Dong Gwan HAN
Journal of the Korean Pediatric Society 1993;36(4):574-578
Cerebrocostomandibular syndrome is characterized by micrognathia, cleft palate, multiple thorax deformity and frequently, mental deficiency. Respiratory compromise is a common cause of death. We experienced a case of cerebrocostomandibular syndrome with congenital heart disease in a 2 day old female baby with the chief complaint of cyanosis and respiratory difficulty since birth. She was delivered by cesarian section due to delayed labor at IUP 42 weeks. The diagnosis was made on the basis of clinical features, radiologic findings and echocardiogram, which showed micrognathia, deformity of 3rd finger Lt, hemivertebrae of T1-T6 Lt., absence of 1-6th rib Lt., dextrocardia, tetralogy of fallot, atrial septal defect secondum. We reported this case and reviewed related litertures briefly.
Cause of Death
;
Cleft Palate
;
Congenital Abnormalities
;
Cyanosis
;
Dextrocardia
;
Diagnosis
;
Female
;
Fingers
;
Heart Defects, Congenital*
;
Heart Septal Defects, Atrial
;
Humans
;
Intellectual Disability
;
Parturition
;
Ribs
;
Tetralogy of Fallot
;
Thorax
4.Clinical Nurses' lived Experience of Interpersonal Relations in the Ward Setting of the hospital.
Yang Heui AHN ; Dae Ran KIM ; Bok Nam SEO ; Kyoung Eui LEE ; Eun Ha LEE ; Eun Shil YIM
Journal of Korean Academy of Nursing 2002;32(3):295-304
PURPOSE: The purpose of the study was to describe the essential structure of the lived experience of clinical nurses' interpersonal relations among nurses, patients, and others in the ward setting of the hospital. METHOD: Six nurses who have experienced from 4 to 7 years on the same ward setting, were interviewed. The data were collected from September, 2000 to May, 2001 and analyzed using Colaizzi's (1978) method of phenomenology. RESULT: In this study, 7 themes were extracted: difficulty of interpersonal relations after being familiar with work, developing good relations with doctors, patients, and their significant others as experience increased, generation gap among individual nurses, evaluating other nursing colleagues on their past experience in ward settings, avoiding nurses with whom one was in conflict, sometimes, resolving conflict through getting together with colleagues informally, having a limited interpersonal network, experiencing becoming mature through struggling with the difficulty of interpersonal relations. CONCLUSION: Nurse managers need to provide resources, opportunities, and information to clinical nurses through fully understanding the characteristics of nurses' interpersonal relations. In addition, they should minimize the factors which intervene with good interpersonal relations among clinical nurses.
Humans
;
Intergenerational Relations
;
Interpersonal Relations*
;
Nurse Administrators
;
Nursing
5.Job Performance of Occupational Health Personnel.
Yun Chul HONG ; Eun Hee HA ; Kyung Ja JUN ; Young Man RHO ; Hye Sook PARK ; Heui Sug JO ; Hun Jae LEE ; Mi Ran YANG
Korean Journal of Occupational and Environmental Medicine 1997;9(3):496-507
No abstract available.
Occupational Health*
6.Sequence Varation of 5(1) Nontranslating Region of Enterovirus Isolated from Patients with Aseptic Meningitis.
Young Chul PARK ; Jung Hyun NAM ; Chul Hyun JOO ; Mi Sun MOON ; Kyoung Won CHUNG ; Heui Ran LEE ; Yung Keol CHO ; Yoo Kyum KIM
Journal of Bacteriology and Virology 2001;31(1):85-94
No abstract available.
Enterovirus*
;
Humans
;
Meningitis, Aseptic*
7.Effect of Salinity, Temperature, and Glucose on the Production of Vibrio vulnificus Hemolysin.
Hyun Soo KIM ; Sung Heui SHIN ; Hae Ryoung PARK ; Shee Eun LEE ; Choon Mee KIM ; Soo Young KIM ; Young Ran KIM ; Hyun Chul LEE ; Sun Sik CHUNG ; Joon Haeng RHEE
Journal of Bacteriology and Virology 2002;32(4):355-366
Among the exotoxins produced by V. vulnificus, hemolysin (HS) has been reported to be the most potent one. To investigate the factors up- or down-regulating HS production in the context of pathogenesis, we observed the effects of salinity or/and temperature shifting, glucose, and acidic pH on the production of HS by V. vulnificus C7184 strain in vitro. Significantly more HS was produced when V. vulnificus was cultured in 0.9% salinity and 37 degrees C than in 2.5% and 25 degrees C. When the culture condition reflecting natural habitat of V. vulnificus (2.5% salinity and 25degrees C) was changed into that reflecting human body (0.9% salinity and 37 degrees C), 2.5 fold or more HS was produced than in the V. vulnificus being cultured continuously in 0.9% NaCl at 37 degrees C. This result suggests that V. vulnificus somehow recognizes the shifting in salinity and temperature and stimulate HS production. Glucose addition in the culture medium resulted in a dose- dependent decrease in the HS production. Glucose itself and acidic pH resulting from its metabolism both appeared to inhibit the HS production. Glucose in itself had more dominant role in suppressing the HS production than the lowered pH accompanying the metabolism of glucose. This result suggests that HS production is down-regulated in the presence of glucose and under environmental acidic pH.
Ecosystem
;
Exotoxins
;
Glucose*
;
Human Body
;
Hydrogen-Ion Concentration
;
Metabolism
;
Salinity*
;
Vibrio vulnificus*
;
Vibrio*
;
Virulence
8.Enhanced Effect of Iodide - Uptake in Thyroid Carcinoma Cells by Infecting Adenovirus - Human Sodium Iodide Symporter (Ad - hNIS).
Kun Koo PARK ; Jung Sun JIN ; Seong Jin LEE ; Jung Yoon PARK ; Heui Ran LEE ; Dae Hyuk MOON ; Il Min AHN ; Hye Sook CHANG
Journal of Korean Society of Endocrinology 2000;15(4-5):522-531
BACKGROUND: The sodium-iodide-symporter (NIS) is a plasma membrane glycoprotein with 13 putative transmembrane domains, which is responsible for concentrating iodide into the thyroid by an active transport and provides the mechanism for radioactive-iodine (RAI) therapy for thyroid cancer. However, undifferentiated thyroid cancers and about 2050% of differentiated thyroid cancers do not take up the RAI at therapeutic dose. The NIS has been cloned from rat and human (hNIS) and characterized recently. In an attempt to develop a new therapeutic strategy using hNIS gene for improving the efficacy of RAI therapy in thyroid cancers, we have constructed a recombinant adenovirus encoding the hNIS (Ad-hNIS) and tested its function by an iodide uptake by infecting human thyroid cancer cells. METHODS: RT-PCR was performed to measure an intrinsic hNIS expression in thyroid cancer cell lines, such as NPA, FRO and ARO. To generate the hNIS adenovirus, hNIS cDNA was isolated and ligated into Swa I site of cosmid shuttle vector (pAxCAwt). We have produced recombinant adenovirus by co-transfecting the cosmid with DNA-TPC to 293 cell line. Adenovirus that express (beta-Galactosidase (LacZ) was also prepared by the similar strategy. Adenovirus infection efficiency was measured in three thyroid cancer cell lines. Finally, 24 hours after infection of ad-hNIS into the cells, I125-uptake was measured. RESULTS: Endogenous hNIS expression was detected only in FRO cells but not in NPA, ARO and Hela cells by RT-PCR. X-Gal staining after infection of Ad-LacZ to thyroid cancer cell (NPA, ARO, FRO) showed that an infection rate in ARO cells was 98.5+0.5%, 97.0+0.2% in FRO cells and 75.5+5.0% in NPA cells. We selected ARO cells for the infection of Ad-hNIS due to the highest infection efficiency and the absence of endogenous hNIS expression. When ARO cells were infected with the ad-hNIS, I125 uptake was increased 504+6.4%. CONCLUSION: Overexpression of hNIS gene in thyroid cancer cells elicited over 5 fold increase in I-uptake, suggesting that the Ad-hNIS infection to the thyroid cancer cells may improve the efficiency of radioactive iodine therapy.
Adenoviridae Infections
;
Adenoviridae*
;
Animals
;
Biological Transport, Active
;
Cell Line
;
Cell Membrane
;
Clone Cells
;
Cosmids
;
DNA, Complementary
;
Genetic Therapy
;
Genetic Vectors
;
Glycoproteins
;
HeLa Cells
;
Humans*
;
Iodine
;
Ion Transport*
;
Rats
;
Sodium Iodide*
;
Sodium*
;
Thyroid Gland*
;
Thyroid Neoplasms*
9.Development of Occupation Health Information System based on the Internet.
Eun Hee HA ; Yun Chul HONG ; Young Man RHO ; Cheol Hwan KIM ; Kyung Ja JUNE ; Haeng LEE ; Hye Sook PARK ; Mi Ran YANG ; Heui Sug JO ; Jae Bum SHIM
Journal of Korean Society of Medical Informatics 1997;3(2):161-168
Recently the changes in medical informatics enabled us to use medical information whenever we want and wherever we are. However, there are few information supporting systems on the web in occupational health field. So we have tried to make an occupational health information system (OHIS) based on the Internet and to provide occupational information to occupational health personnel. There were two steps for developing OHIS. First, we analyzed user's needs and existing information systems and then developed contents of our OHIS. Second, we constructed web server under the environment of Windows user, using operating system of windows NT 4.0 and web browsers of Netscape Navigator. Many users in worksites wanted information through the Internet. The contents of OHS which they wanted were information related to health education of workers, health counselling, news, and so on. The contents of OHIS which we forwarded were occupational health service, information about organization of occupational health, book references and journals, link-sites related to occupational health. In the future, this Interned-based OHIS will be an useful site offering a lot of information to occupational health personnel.
Health Education
;
Health Information Systems*
;
Information Systems
;
Internet*
;
Medical Informatics
;
Occupational Health
;
Occupational Health Services
;
Occupations*
;
Web Browser
;
Workplace
10.Systemic Candidiasis in Neonatal Intensive Care Unit : A 8-Year Experience.
Do Hyeon KIM ; Jin A LEE ; Heui Seung JO ; Kyung Ran PARK ; June Dong PARK ; Beyong Il KIM ; Jung Hwan CHOI
Journal of the Korean Society of Neonatology 2001;8(1):33-45
PURPOSE: Recently, Candida has become an increasingly significant neonatal pathogen, and may result in serious morbidity and mortality in the neonatal intensive care units. The purpose of this study was to describe and analyze our 8-year experiences with a review of the related literature, and to contribute to the improvement of the survival rate in the neonatal intensive care unit. METHODS: We retrospectively reviewed the medical records of 20 patients who were diagnosed as systemic candidiasis in the neonatal intensive care unit of Seoul National University Children's Hospital between January 1993 and December 2000. We then analyzed demographics, clinical presentations, diagnostic features, risk factors, antifungal therapy, and outcomes. RESULTS: Twenty-one systemic candidial infections occurred in 20 patients representing 0.85% of all NICU patients during the study period, among which 13 were very low birth weight (VLBW) infants (2.85% of total 456 VLBW infants). The mean gestational age and birth weight were 30.4 weeks and 1,430 gm, respectively. The common Candida species were C. albicans (61.9%), C. parapsilosis (38.1%), and the others such as C. glabrata (4.8%), C. tropicalis (4.8%), and C. famata (4.8%). The rates of culture positivity of blood, urine, and tracheal aspirates were 95.2%, 42.9%, and 9.5%, respectively. Each of candidial endocarditis, peritonitis, and renal fungus ball developed in a different patient. The most common presenting clinical signs were respiratory deterioration, abdominal distension, and apnea/bradycardia. All patients were treated with amphotericin B, alone in 9 cases or in combination with 5-flucytosine (7 cases) and with fluconazole (4 cases). Systemic candidiasis contributed to the deaths of 6 patients (30%). CONCLUSION: In the neonatal intensive care unit of Seoul National University Children's Hospital, systemic candidiasis was a serious infection associated with high mortality and the diverse clinical features. Early diagnosis and appropriate antifungal therapy, combined with the elimination of the risk factors, may guarantee lower morbidity and mortality in the neonatal systemic candidiasis.
Amphotericin B
;
Birth Weight
;
Candida
;
Candidiasis*
;
Demography
;
Early Diagnosis
;
Endocarditis
;
Fluconazole
;
Fungi
;
Gestational Age
;
Humans
;
Infant
;
Infant, Newborn
;
Infant, Very Low Birth Weight
;
Intensive Care Units, Neonatal
;
Intensive Care, Neonatal*
;
Medical Records
;
Mortality
;
Peritonitis
;
Retrospective Studies
;
Risk Factors
;
Seoul
;
Survival Rate